VAERS reports by lot

GSK Varicella/Shingles lot FG2D4: VAERS reports

26 VAERS reports list lot FG2D4 as a GSK Varicella/Shingles vaccine, received between 2019-05-08 and 2019-11-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
4%
Marked serious
0
With a death outcome
5
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2925%
Injection-site / Local reaction2724%
Neurological1715%
Dermatological (non-injection-site)1412%
Musculoskeletal109%
Cardiac / Cardiovascular54%
Allergic / Anaphylactic44%
Gastrointestinal44%
Respiratory22%
Psychiatric / Neuropsychiatric22%

Where reports came from

U.S. state of the reporter, where given (top 12).

Virginia4
Ohio4
Georgia3
Pennsylvania2
New York2
California1
Tennessee1
District of Columbia1
Michigan1
Florida1
Massachusetts1
South Carolina1

Reports by month received

2019-059
2019-068
2019-075
2019-083
2019-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.